This full-day virtual symposium will provide discussion necessary to raise the awareness of PrEP availability for women in order to strengthen HIV prevention efforts in this population. 

Objectives:

1. Describe the current treatment guidelines for PrEP
2. Describe how women are impacted by HIV and how they may benefit from PrEP
3. Describe management of significant sexually transmitted infections
4. Identify challenges and barriers to PrEP (Domestic Violence)
5. Demonstrate sexual history taking skills and increase comfort discussing sexuality with women
6. PrEP and Serodiscordant Couples
7. Discuss patient education with practical approaches for patients to adhere to medication and follow-up clinic visits

Targeted Audience: Clinicians, Pharmacists, Nurses, Social Workers, Allied Health Professionals, CHW

Credits: CME, CNE, CPE, CPH, CEU, CECH

ACCREDITATION STATEMENTS:

CME:  The Centers for Disease Control and Prevention designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive .65 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-21-254-L01-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline.  Official credit will be uploaded within 60 days on the NABP/CPE Monitor

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer .7 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES^®) and/or Master Certified Health Education Specialists (MCHES^®) to receive up to 6.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. Continuing Competency credits available are 6.5. CDC provider number 98614.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 7.0 CPH recertification credits for this program.

DISCLOSURE:  In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, our presenters (for enduring material, use “content experts” instead of “presenters”), and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Jones Parker and she wishes to disclose she is on the speaker’s bureau for Gilead Janssen.  Also, Dr. Anderson and she wishes to disclose she has stock with Pfizer and Abbvie Pharma.  She also has research supported by Gilead.  Planning committee discussed conflict of interest with Dr. Jones Parker and Dr. Anderson to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

Questions? Contact Dorcas Baker at dbaker4@jhu.edu